Modulation of tyrosine phosphorylation signalling pathways by 1α,25(OH)2-vitamin D3

Trends in Endocrinology and Metabolism

Volumn 16, Issue 6, 2005, Pages 280-287

  Boland, Ricardo ^a   Buitrago, Claudia ^a   De Boland, Ana Russo ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM ION; CELL NUCLEUS RECEPTOR; COLECALCIFEROL DERIVATIVE; GROWTH FACTOR; MEMBRANE RECEPTOR; MINERAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE; STEROID HORMONE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VITAMIN D RECEPTOR;

APOPTOSIS; BONE; BONE CELL; CALCIUM METABOLISM; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOCRINE SYSTEM; EPIDERMIS; HUMAN; IMMUNE SYSTEM; INTESTINE; INTESTINE CELL; KERATINOCYTE; MAMMAL CELL; METABOLISM; MINERAL METABOLISM; MUSCLE; MUSCLE CONTRACTILITY; MUSCLE GROWTH; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN; TRANSCRIPTION REGULATION;

CHOLECALCIFEROL; HUMANS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 23044438121     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2005.06.003     Document Type: Review

References (84)

1. Ikekawa, N. and Ishizuka, S. (1993) Molecular structure and biological activity of vitamin D metabolites and their analogs. In Molecular Structure and Biological Activity of Steroids, pp. 293-316, CRC Press
2. 3 stimulated calcium absorption and clarify its immunomodulatory properties Arch. Biochem. Biophys. 432 2004 152 166
3. 3-regulated gene expression by microarray analysis J. Steroid Biochem. Mol. Biol. 89-90 2004 239 244
4. 2-vitamin D3 mediated rapid and genomic responses are dependent upon critical structure-function relationships for both the ligand and the receptor D. Feldman Vitamin D 2005 Elsevier-Academic Press 381 407
5. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle membranes in skeletal muscle cells J. Cell. Biochem. 86 2002 128 135
6. 3 Mol. Cell. Endocrinol. 197 2002 1 13
7. C. Widmann Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human Physiol. Rev. 79 1999 143 180
8. J.S. Gutkind Regulation of mitogen-activated protein kinase signalling networks by G protein-coupled receptors Sci. STKE 2000 10.1126/stke.2000.40.re1 (http://stke.sciencemag.org )
9. E. Cano, and L.C. Mahadevan Parallel signal processing among mammalian MAPKs Trends Biochem. Sci. 20 1995 117 122
10. H. Ichijo From receptors to stress-activated MAP kinase Oncogene 18 1999 6087 6093
11. T. Obata MAP kinase pathways activated by stress: the p38 MAPK pathway Crit. Care Med. 28 2000 N67 N77
12. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
13. G. Pearson Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22 2001 153 183
14. M.J. Robinson, and M.H. Cobb Mitogen-activated protein kinase pathways Curr. Opin. Cell Biol. 9 1997 180 186
15. Y. Kato Role of BMK1 in regulation of growth factor-induced cellular responses Immunol. Res. 21 2000 233 237
16. Z. Wu p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps Mol. Cell. Biol. 20 2000 3951 3964
17. R. Boland Role of vitamin D in skeletal muscle function Endocr. Rev. 7 1986 434 448
18. R. Boland Vitamin D and muscle D. Feldman Vitamin D 2005 Elsevier-Academic Press 883 897
19. 3 signal transduction in skeletal muscle cells J. Biol. Chem. 275 2000 36021 36028
20. 3 signalling to the nucleus in muscle cells Biochim. Biophys. Acta 1541 2001 179 187
21. 3 regulation of the mitogen-activated protein kinase pathway in muscle cells J. Biol. Chem. 278 2003 2199 2205
22. 3 in skeletal muscle cells is mediated by protein kinase C and calcium Mol. Cell. Endocrinol. 173 2001 41 52
23. 3. Activation of muscle cell PLCγ through the tyrosine kinase c-Src and PtdIns 3-kinase Eur. J. Biochem. 269 2002 2506 2515
24. 3 Biochem. Mol. Biol. Int. 31 1993 677 684
25. 2+ influx in skeletal muscle cells. Modulation by phospholipase C, protein kinase C, and tyrosine kinases J. Biol. Chem. 273 1998 33954 33960
26. 3-induced differentiation in human osteoblasts Immunopharmacol. Immunotoxicol. 24 2002 31 41
27. 3 24R-hydroxylase activity in growth zone costochondral growth plate chondrocytes via protein kinase C Calcif. Tissue Int. 69 2001 365 372
28. S. Yarram Epidermal growth factor and calcitriol synergistically induce osteoblast maturation Mol. Cell. Endocrinol. 220 2004 9 20
29. 3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signalling via the Janus kinase (JAK2)-signal transducers and activators of transcription (STAT5) system in osteoblast-like cells J. Biol. Chem. 277 2002 34879 34884
30. 3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells Endocrinology 145 2004 87 94
31. 3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase J. Cell. Biochem. 67 1997 432 438
32. 3-induced osteoclastogenesis in a mouse co-culture system Exp. Physiol. 88 2003 569 574
33. X. Li p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function Endocrinology 143 2002 3105 3113
34. S. Suhr Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption J. Bone Miner. Res. 16 2001 1795 1803
35. R.L. Eckert Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase J. Investig. Dermatol. Symp. Proc. 7 2002 36 40
36. 3 in normal human keratinocytes J. Invest. Dermatol. 106 1996 1212 1217
37. R. Gniadecki Nongenomic signalling by vitamin D: a new face of Src Biochem. Pharmacol. 56 1998 1273 1277
38. 3-induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity J. Invest. Dermatol. 114 2000 1174 1179
39. 3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes J. Invest. Dermatol. 120 2003 561 570
40. A. Ravid Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes J. Endocrinol. 173 2002 525 532
41. T. Diker-Cohen Vitamin D protects keratinocytes from apoptosis induced by osmotic shock, oxidative stress, and tumor necrosis factor Ann. N. Y. Acad. Sci. 1010 2003 350 353
42. 3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes J. Cell. Biochem. 89 2003 663 673
43. A. Gamady Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes J. Cell. Biochem. 89 2003 440 449
44. 3 signalling in chick enterocytes: enhancement of tyrosine phosphorylation and rapid stimulation of mitogen-activated protein (MAP) kinase J. Cell. Biochem. 69 1998 470 482
45. 3 in rat intestinal cells: effect of ageing Int. J. Biochem. Cell Biol. 36 2004 489 504
46. 3 stimulates activator protein-1-dependent Caco-2 cell differentiation J. Biol. Chem. 274 1999 35505 35513
47. 3 stimulates phospholipase C-γ in rat colonocytes: role of c-Src in PLC-γ activation J. Clin. Invest. 99 1997 1831 1841
48. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia J. Biol. Chem. 269 1994 23750 23756
49. 3 J. Cell. Biochem. 78 2000 34 46
50. 3 correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction J. Cell. Biochem. 79 2000 274 281
51. 3 Biochem. Biophys. Res. Commun. 289 2001 1150 1156
52. 3 by VDR-dependent and -independent mechanisms in muscle cells Steroids 67 2002 477 482
53. 3-induced SOC influx in muscle cells Int. J. Biochem. Cell Biol. 36 2004 1910 1918
54. J.S. Adams Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism J. Steroid Biochem. Mol. Biol. 89-90 2004 461 465
55. 3 in MCF-7 breast cancer cells J. Cell. Biochem. 93 2004 384 397
56. 3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes Endocrinology 140 1999 713 721
57. 3 increases epidermal growth factor receptors and transforming growth factor β-like activity in a bone-derived cell line J. Biol. Chem. 262 1987 13424 13428
58. 3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of p38-mitogen-activated protein kinase Arch. Biochem. Biophys. 398 2002 1 6
59. 3 down-regulates cell membrane growth and nuclear growth-promoting signals by the epidermal growth factor receptor J. Biol. Chem. 277 2002 38965 38971
60. 3 on binding and internalization of epidermal growth factor in culture cells. Studies on BT-20 cells using quantitative electron microscopy autoradiography Exp. Cell Res. 184 1989 329 341
61. K.R. McGaffin Growth and EGFR regulation in breast cancer cells by vitamin D and retinoid compounds Breast Cancer Res. Treat. 86 2004 55 73
62. C. Benz Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Breast Cancer Res. Treat. 24 1993 85 92
63. D. Ignar-Trowbridge Coupling of dual signalling pathways: epidermal growth factor action involves the estrogen receptor Proc. Natl. Acad. Sci. U. S. A. 89 1992 4658 4666
64. R.J. Pietras Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature Breast J. 9 2003 361 373
65. C. Lange Convergence of progesterone and epidermal growth factor signalling in breast cancer J. Biol. Chem. 273 1998 31308 31316
66. N. Craft A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signalling by the HER-2/neu tyrosine kinase Nat. Med. 5 1999 280 285
67. S. Yeh From HER2/neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proc. Natl. Acad. Sci. U. S. A. 96 1999 5458 5463
68. 3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway Am. J. Physiol. Cell Physiol. 285 2003 C1122 C1130
69. 3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5 J. Biol. Chem. 277 2002 29643 29653
70. H. Hara Alteration of cellular phosphorylation state affects vitamin D receptor mediated CYP3A4 mRNA induction in Caco-2 cells Biochem. Biophys. Res. Commun. 296 2002 182 188
71. 3 24-hydroxylase transcription Am. J. Physiol. Endocrinol. Metab. 286 2003 E598 E608
72. E. Tagliafico Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation Oncogene 22 2003 1712 1723
73. J.S. Sebolt-Leopold, and R. Herrera Targeting the mitogen-activated protein kinase cascade to treat cancer Nat. Rev. Cancer 4 2004 937 947
74. J.M. Olson, and A.R. Hallahan p38 MAP kinase: a convergence point in cancer therapy Trends Mol. Med. 10 2004 125 129
75. N.J. Kennedy, and R.J. Davis Role of JNK in tumor development Cell Cycle 2 2003 199 201
76. 3 induced and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells Biochem. Biophys. Res. Commun. 241 1997 419 426
77. 3 in promyelocytic in NB4 leukemia cells: a structure-function study Endocrinology 139 1998 457 465
78. 3-induced differentiation of HL-60 cells J. Cell. Biochem. 80 2001 471 482
79. 3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells Cell Cycle 1 2002 410 415
80. 3-induced monocytic differentiation of HL-60 cells Cancer Res. 64 2004 370 377
81. 3-induced growth inhibition J. Biol. Chem. 277 2002 25884 25892
82. 3 analogue EB1089 in NCI-H92 myeloma cells via activation of caspase 3 and p38 MAP kinase Br. J. Haematol. 109 2000 576 583
83. 3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro Blood 101 2003 2454 2460
84. 3-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK1 J. Biol. Chem. 276 2001 26365 26373